Life Stem Genetics
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti… Read more
Market Cap & Net Worth: Life Stem Genetics (LIFS)
Life Stem Genetics (PINK:LIFS) has a market capitalization of $24.58K ($24.58K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51540 globally and #16219 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Life Stem Genetics's stock price $0.00 by its total outstanding shares 245837500 (245.84 Million).
Life Stem Genetics Market Cap History: 2015 to 2025
Life Stem Genetics's market capitalization history from 2015 to 2025. Data shows change from $24.58K to $24.58K (-21.63% CAGR).
Life Stem Genetics Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Life Stem Genetics's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LIFS by Market Capitalization
Companies near Life Stem Genetics in the global market cap rankings as of March 18, 2026.
Key companies related to Life Stem Genetics by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Life Stem Genetics Historical Marketcap From 2015 to 2025
Between 2015 and today, Life Stem Genetics's market cap moved from $24.58K to $ 24.58K, with a yearly change of -21.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $24.58K | 0.00% |
| 2024 | $24.58K | -96.55% |
| 2023 | $712.93K | +480.00% |
| 2022 | $122.92K | +400.00% |
| 2021 | $24.58K | 0.00% |
| 2018 | $24.58K | -50.00% |
| 2016 | $49.17K | +100.00% |
| 2015 | $24.58K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Life Stem Genetics was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.58K USD |
| MoneyControl | $24.58K USD |
| MarketWatch | $24.58K USD |
| marketcap.company | $24.58K USD |
| Reuters | $24.58K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.